InvaGen Pharmaceuticals, Inc. et al. v. Bayer Pharma AG et al. > Summary
Court Case Number IPR2022-01515
Filing Date Sep 8, 2022
Institution Decision Date Oct 19, 2022
Decision Date Jan 12, 2026
Court Patent Trial and Appeal Board
Status Terminated
Appeal2023-2434
Administrative JudgesTina E. Hulse, Robert A. Pollock, Ryan H. Flax
Judge Writing the Final DecisionTina E. Hulse
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8
Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8
Petitioner
Patent Owner
Petitioner Attorneys
9InvaGen Pharmaceuticals, Inc.
Attorney Name: Neal Seth
Wiley Rein LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: Teresa Summers
Wiley Rein LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: Mark J. Eisenberg
THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
InvaGen Pharmaceuticals, Inc.
Attorney Name: Richard L. Torczon Jr.
Wilson Sonsini Goodrich & Rosati
Attorney Name: Chandrika Vira
Sterne, Kessler, Goldstein & Fox
Attorney Name: Trey Powers III
Sterne, Kessler, Goldstein & Fox
Attorney Name: Wendy L. Devine
Wilson Sonsini Goodrich & Rosati
Attorney Name: Susannah M. L. Gagnon
Wilson Sonsini Goodrich & Rosati
Attorney Name: Ellie F. Steiner
Wilson Sonsini Goodrich & Rosati
Patent Owner Attorneys
2Bayer Pharma AG
Attorney Name: Julie L. Tavares
Williams & Connolly
Bayer Pharma AG
Attorney Name: Dov P. Grossman
Williams & Connolly
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |
